Holders

ARROWHEAD PHARMACEUTICALS IN

Q1 2026 13F holders

CUSIP
04280AAC4
Type
Debt
Class
NOTE 1/1
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Principal Option type